Ligand Pharmaceuticals Incorporated (LGND)
$303.53-2.44%Close
BUYRECOVERY · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6.1B
- Beta
- 1.01
- P/E (TTM)
- 30.32
- Short % float
- 13.70%
- Days to cover
- 8.7
- SI change
- +1.7%
- 1W
- +2.22%
- 1M
- +8.15%
- vs SPY 1W
- +2.36%
- vs SPY 1M
- +5.65%
Industry peers
FMP comparable companies · ranked by market cap
- ABBVBUYAbbVie Inc.$496.5BBULLQ 29$281.04-2.40%
- AMGNBUYAmgen Inc.$225.4BRECOVERYQ 22$417.57-1.13%
- PFESELLPfizer Inc.$161.9BBULLQ 13$28.40-0.11%
- BMYSELLBristol-Myers Squibb Company$117.6BBEARQ 10$57.58-1.58%
- GMABBUYGenmab A/S$22.9BBULLQ 21$37.37-2.14%
- INCYSELLIncyte Corporation$22.6BBEARQ 13$111.36-2.46%
- EXELBUYExelixis, Inc.$15.0BBULLQ 10$59.82-0.52%
- BCRXSELLBioCryst Pharmaceuticals, Inc.$2.1BRECOVERYQ 6$8.36-3.47%
- RIGLBUYRigel Pharmaceuticals, Inc.$903MBULLQ 9$48.81-3.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on LGND?
- LOPJLB’s latest quantitative signal on Ligand Pharmaceuticals Incorporated (LGND) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is LGND in?
- Ligand Pharmaceuticals Incorporated (LGND) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Ligand Pharmaceuticals Incorporated (LGND) do?
- Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis a…